(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

AVITI

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

AVITI

ST13

US500000090981599

Class

1, 5, 9

Filing

90981599

Registration

8103398

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

48

Latest update

01/13/2026

Trademark type

Word

Nice classes

1, 5, 9

Filing date

06/11/2021

Registration date

01/13/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/13/2026

Last transaction

01/13/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

03/14/2023

First use in commerce

03/14/2023

Drawing code

4

Owner type

03

Owner location

San Diego, CA

Examiner

LE, KHANH M

Law office

M70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Element Biosciences, Inc.

Representatives

Samantha C. Markley LOZA & LOZA, LLP

Technical classification

Nice Classes

Class 1Class 5Class 9

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Assays and reagents for use in genetic research; diagnostic reagents for scientific or research use; diagnostic reagents for clinical or medical laboratory use; reagents and reagent kits comprised primarily of nucleic acidsnaturally occurring or modified nucleotidesenzymeslabelsbuffersall for the purpose of preparingdetectingsequencinganalyzing nucleic acids and other biological moleculessamples of biological moleculesgenesgenomesnucleotide sequence variants and modificationsregulationtranscriptionexpression for scientific research usefor diagnostic scientific usefor clinical laboratory research use; clinical diagnostic reagents for laboratory use; reagent kits and reagent beads with attached biomoleculescomprised primarily of oligonucleotides and other nucleic acidsnatural and modified nucleotidespolypeptidesbufferslabelssubstratesfor clinical diagnostic laboratory purposes

Class 5

Medical diagnostic reagents; clinical medical diagnostic reagents; reagent kits and reagent beads with attached biomoleculescomprised primarily of oligonucleotides and other nucleic acidsnatural and modified nucleotidespolypeptidesbufferslabelssubstratesfor clinical medical diagnostic purposes; reagents and reagent kits comprised primarily of nucleic acidsnaturally occurring or modified nucleotidesenzymeslabelsbuffersall for the purpose of preparingdetectingsequencinganalyzing nucleic acids and other biological moleculessamples of biological moleculesgenesgenomesnucleotide sequence variants and modificationsregulationtranscriptionexpression for diagnostic medical use and for clinical medical use

Class 9

Computer systemscomputer hardwaredownloadable and recorded computer software and associated downloadable data files for collectingstoringanalyzing and reporting biological informationfor sample tracking and managing projectslaboratory workflow and dataall the foregoing for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; downloadable and recorded computer software for data collectionmanagementanalysis of genetic information for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; clinical diagnostic instruments for scientific usenucleic acid sequencersimaging devices and analyzers

Publications

History of USPTO decisions and trademark events.

48 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/13/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

01/13/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/07/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/07/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/07/2026

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

12/22/2025

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

12/22/2025

SUPC

STATEMENT OF USE PROCESSING COMPLETE

12/15/2025

DPCC

DIVISIONAL PROCESSING COMPLETE

12/15/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

12/15/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

12/10/2025

IUAF

USE AMENDMENT FILED

10/24/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/24/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/24/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/24/2025

DRRR

DIVISIONAL REQUEST RECEIVED

06/12/2025

EISU

TEAS STATEMENT OF USE RECEIVED

06/12/2025

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

06/12/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/03/2025

EX4G

SOU EXTENSION 4 GRANTED

12/07/2024

EXT4

SOU EXTENSION 4 FILED

12/07/2024

EEXT

SOU TEAS EXTENSION RECEIVED

12/06/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

06/13/2024

EX3G

SOU EXTENSION 3 GRANTED

06/10/2024

EXT3

SOU EXTENSION 3 FILED

06/10/2024

EEXT

SOU TEAS EXTENSION RECEIVED

06/10/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

12/02/2023

EX2G

SOU EXTENSION 2 GRANTED

11/30/2023

EXT2

SOU EXTENSION 2 FILED

11/30/2023

EEXT

SOU TEAS EXTENSION RECEIVED

11/30/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

06/08/2023

EX1G

SOU EXTENSION 1 GRANTED

06/06/2023

EXT1

SOU EXTENSION 1 FILED

06/06/2023

EEXT

SOU TEAS EXTENSION RECEIVED

06/06/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

12/13/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/18/2022

PUBO

PUBLISHED FOR OPPOSITION

10/18/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/28/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/12/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/01/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/31/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/31/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/07/2022

GNRT

NON-FINAL ACTION E-MAILED

03/07/2022

CNRT

NON-FINAL ACTION WRITTEN

03/07/2022

DOCK

ASSIGNED TO EXAMINER

02/28/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/01/2021

NWAP

NEW APPLICATION ENTERED

06/15/2021

Continuous trademark protection

Get notified about every new filing that threatens AVITI or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.